Single Use Instrument recommendations set to stimulate reform in decontamination procedures?

Article

The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times.

The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times, according to ophthalmic instrument supplier John Weiss & Son, Ltd.

Although the heightened requirements for handcrafted reusable instruments remains a production priority for many manufacturers, the significant requirement for single use instruments alongside reusable products cannot be ignored.

This is evidenced by the foundation of The Eyeline Organisation, an international group of ophthalmologists whose aim is to apply cutting edge innovation to the design and quality of single use instruments. Eyeline manufactures instruments including forceps, needleholders, scissors and a variety of manipulators and probes. The ACROfine dispøz Single Use Instruments manufactured by Eyeline have recently been released by John Weiss, and are available in procedure packs for phaco, sub-tenons, oculoplastic, and intravitreal injections.

"This unique relationship will offer surgeons the single use solution they never expected," explains Michael Bench, managing director of John Weiss.

www.johnweiss.com

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.